Jeffrey Nugent
Board Member

Chairman, CEO Sientra

Jeffrey Nugent has served as a member of our board of directors since September 2015. Mr. Nugent is Chairperson of the compensation committee and also serves on our audit committee. Since November 2015, Mr. Nugent has served as Chairman and Chief Executive Officer of Sientra. Mr. Nugent had served as a director to Sientra since July 2014. Mr. Nugent's prior experiences include serving as CEO and Worldwide President of Neutrogena where he led the acquisition by Johnson & Johnson and quadrupled sales to $1B within 4 years. Neutrogena is regarded as one of the most successful acquisitions in J&J history. Following Neutrogena, he became President and CEO of Revlon where he led a turnaround in profitability and a global initiative of new product innovation. This highly leveraged entity posed a significant challenge of meeting covenant commitments while moving the brands forward both in terms of revenue growth and profitability. He was Founder, President and CEO of Precision Dermatology, a multi - channel dermatology and skin care company he established in 2010. The company grew organically and by M&A and was acquired by Valeant Pharmaceuticals for $500MM in 2013. Mr. Nugent most recently served as Interim President, CEO and member of the Board of Directors of Biolase (Nasdaq) between 2014 and 2015. Biolase is the world's largest manufacturer and distributor of medical lasers primarily to the dental profession and a significant turnaround situation. Within three quarters, the core laser franchise returned to growth following over two years of decline. He began his career at J&J where he held senior positions in all three business sectors. Mr. Nugent holds an MBA in Finance and Marketing from Loyola University of Chicago and BS in Mathematics from St. Joseph's College.
[Back to Board]